CA2565068A1 - Animal transgenique non humain comme modele pour des maladies neurodegeneratives et pour le diagnostic precoce de ces maladies - Google Patents
Animal transgenique non humain comme modele pour des maladies neurodegeneratives et pour le diagnostic precoce de ces maladies Download PDFInfo
- Publication number
- CA2565068A1 CA2565068A1 CA002565068A CA2565068A CA2565068A1 CA 2565068 A1 CA2565068 A1 CA 2565068A1 CA 002565068 A CA002565068 A CA 002565068A CA 2565068 A CA2565068 A CA 2565068A CA 2565068 A1 CA2565068 A1 CA 2565068A1
- Authority
- CA
- Canada
- Prior art keywords
- mice
- human transgenic
- non human
- ngf
- transgenic animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000212A ITRM20040212A1 (it) | 2004-04-30 | 2004-04-30 | Animale transgenico non umano come modello per malattie neurodegenerative e per la loro diagnosi precoce. |
ITRM2004A000212 | 2004-04-30 | ||
PCT/IT2005/000249 WO2005105847A2 (fr) | 2004-04-30 | 2005-04-29 | Animal transgenique non humain comme modele pour des maladies neurodegeneratives et pour le diagnostic precoce de ces maladies |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2565068A1 true CA2565068A1 (fr) | 2005-11-10 |
Family
ID=34979491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002565068A Abandoned CA2565068A1 (fr) | 2004-04-30 | 2005-04-29 | Animal transgenique non humain comme modele pour des maladies neurodegeneratives et pour le diagnostic precoce de ces maladies |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070253907A1 (fr) |
EP (1) | EP1748689A2 (fr) |
JP (1) | JP2008505615A (fr) |
AU (1) | AU2005238317A1 (fr) |
CA (1) | CA2565068A1 (fr) |
IT (1) | ITRM20040212A1 (fr) |
WO (1) | WO2005105847A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
WO2005058479A2 (fr) | 2003-12-17 | 2005-06-30 | Praecis Pharmaceuticals, Inc. | Procedes de synthese de bibliotheques codees |
ITRM20030601A1 (it) | 2003-12-24 | 2005-06-25 | Lay Line Genomics Spa | Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti. |
ITRM20050290A1 (it) | 2005-06-07 | 2006-12-08 | Lay Line Genomics Spa | Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato. |
BRPI0619249A2 (pt) | 2005-11-30 | 2011-09-20 | Abbott Lab | anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos |
CN101506236B (zh) | 2005-11-30 | 2012-12-12 | 雅培制药有限公司 | 抗淀粉样β蛋白的单克隆抗体及其用途 |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
EP2486928A1 (fr) | 2007-02-27 | 2012-08-15 | Abbott GmbH & Co. KG | Procédé pour le traitement des amyloses |
PT2448970E (pt) | 2009-05-04 | 2014-10-20 | Abbvie Res B V | Anticorpos contra factor de crescimento nervoso (ngf) com estabilidade in vivo melhorada |
MX360403B (es) | 2010-04-15 | 2018-10-31 | Abbvie Inc | Proteinas de union a amiloide beta. |
JP6147665B2 (ja) | 2010-08-14 | 2017-06-14 | アッヴィ・インコーポレイテッド | アミロイドベータ結合タンパク質 |
JP6190723B2 (ja) | 2010-12-01 | 2017-08-30 | アルダーバイオ ホールディングス エルエルシー | 抗ngf組成物およびその使用 |
US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
CA2835094C (fr) * | 2011-05-06 | 2020-12-22 | David Gearing | Anticorps contre le facteur de croissance neuronale et leurs procedes de preparation et d'utilisation |
CN114903006A (zh) * | 2021-02-09 | 2022-08-16 | 中国科学院脑科学与智能技术卓越创新中心 | 一种非人灵长类动物物质成瘾模型的构建方法与应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU783964B2 (en) * | 1999-08-06 | 2006-01-05 | S.I.S.S.A. Scuola Internazionale Superiore Di Studi Avanzati | Non-human transgenic animals for the study of neurodegenerative syndromes |
-
2004
- 2004-04-30 IT IT000212A patent/ITRM20040212A1/it unknown
-
2005
- 2005-04-29 AU AU2005238317A patent/AU2005238317A1/en not_active Abandoned
- 2005-04-29 EP EP05742908A patent/EP1748689A2/fr not_active Withdrawn
- 2005-04-29 US US11/579,108 patent/US20070253907A1/en not_active Abandoned
- 2005-04-29 JP JP2007510244A patent/JP2008505615A/ja active Pending
- 2005-04-29 WO PCT/IT2005/000249 patent/WO2005105847A2/fr active Application Filing
- 2005-04-29 CA CA002565068A patent/CA2565068A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2008505615A (ja) | 2008-02-28 |
WO2005105847A3 (fr) | 2006-03-16 |
AU2005238317A1 (en) | 2005-11-10 |
US20070253907A1 (en) | 2007-11-01 |
EP1748689A2 (fr) | 2007-02-07 |
WO2005105847A2 (fr) | 2005-11-10 |
ITRM20040212A1 (it) | 2004-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2565068A1 (fr) | Animal transgenique non humain comme modele pour des maladies neurodegeneratives et pour le diagnostic precoce de ces maladies | |
Venner et al. | A novel population of wake-promoting GABAergic neurons in the ventral lateral hypothalamus | |
Henrich et al. | Determinants of seeding and spreading of α-synuclein pathology in the brain | |
Petkau et al. | Progranulin expression in the developing and adult murine brain | |
Zuko et al. | Contactins: structural aspects in relation to developmental functions in brain disease | |
Kiechle et al. | In vivo protein complementation demonstrates presynaptic α-synuclein oligomerization and age-dependent accumulation of 8–16-mer oligomer species | |
CN103816540B (zh) | 降低β‑抑制蛋白1与APH‑1蛋白的结合的物质在制备防治神经退行性疾病药物中的应用 | |
Kamitakahara et al. | Distinct projection targets define subpopulations of mouse brainstem vagal neurons that express the autism‐associated MET receptor tyrosine kinase | |
Chandra et al. | Gut mucosal cells transfer α-synuclein to the vagus nerve | |
Sarnat | Cerebellar networks and neuropathology of cerebellar developmental disorders | |
CN112189624A (zh) | 一种利用受体基因沉默技术构建和鉴定女性ad模型的方法 | |
Orr et al. | Genotype-specific differences between mouse CNS stem cell lines expressing frontotemporal dementia mutant or wild type human tau | |
US7101845B2 (en) | Methods of modulating β cell function | |
CN110386973A (zh) | 具有多种功能的蛋白多肽及其医药用途 | |
US7273964B1 (en) | Non-human transgenic animals for the study of neurodegenerative syndromes | |
Woelfle et al. | Expression profiles of the autism-related SHANK proteins in the human brain | |
Ourednik et al. | Ectopic expression of the neural cell adhesion molecule L1 in astrocytes leads to changes in the development of the corticospinal tract | |
CN103083645A (zh) | 神经调节素1及其受体作为制备或筛选抗癫痫药物靶点的用途 | |
Thomasen et al. | SorCS2 binds progranulin to regulate motor neuron development | |
KR101592854B1 (ko) | Anks1a 단백질을 포함하는 뇌수종 진단용 바이오마커 조성물 | |
Chen et al. | Epilepsy gene prickle ensures neuropil glial ensheathment through regulating cell adhesion molecules | |
US20230141187A1 (en) | Non-human animal secretome models | |
Bae | Modulation of Perineuronal Nets Regulating Parvalbumin Neuron Maturation in the Mouse Visual Cortex | |
Merheb | Understanding the Pathogenesis of Pol III-related Leukodystrophy | |
AIKEN | Building a brain: interrogating how the α-tubulin gene TUBA1A contributes to neurodevelopment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |